Benefit-Risk Assessment of Medicines

Více o knize

This book presents a universal framework for benefit-risk decisions in pharmaceuticals, addressing the need for a structured approach. It reviews current methodologies and evaluates their effectiveness, offering insights from regulatory authorities. The aim is to create a harmonized system for global benefit-risk assessment.